Copenhagen, Denmark; September 29, 2008 - Genmab A/S (OMX: GEN) announced today that it will host an investor day in Copenhagen, Denmark on October 9, 2008 at 12:30PM CEST (11:30AM BST/6:30AM EDT). Dr. Lisa N. Drakeman, Chief Executive Officer, Professor Jan van de Winkel, President, Research and Development, and David A. Eatwell, Chief Financial Officer will be present at the investor day to discuss Genmab's recent progress and strategy for the future and present Genmab's product pipeline and clinical studies. A webcast of the meeting will be available via live and archived webcast on Genmab's website www.genmab.com.